http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Akers Biosciences (AKER) Receives European Patent Covering Breath Ketone Detector
-
Akers Biosciences Issued European Patent Protection for Breath Ketone Detector
-
Akers Biosciences Announces Conference Call to Discuss Q3 2016 Earnings
-
Akers Biosciences Completes Study on First Rapid Breath Test for Oxidative Stress
-
Akers Biosciences Announces H1 and Q2 2016 Earnings
-
Akers Biosciences Announces Conference Call to Discuss Q2 2016 Earnings
-
Trading Radar for 7/26: Apple (AAPL), McDonald's (MCD), 3M (MMM), Caterpillar (CAT), Verizon (VZ), [Conference Call] Under Armour (UA) Report
-
Akers Biosciences (AKER) Completes PIFA/Chlamydia Rapid Assay Clinical Trial; Notes 'Highly Successful' Results
-
Akers Biosciences Completes Clinical Trial for Rapid Chlamydia Test
-
Akers Biosciences Signs Distribution Agreement for BreathScan OxiChek(TM)
-
Akers Biosciences to Present at LD Micro Invitational Conference
-
Akers Biosciences Reports Earnings for Q1 2016
-
Akers Biosciences Announces Conference Call to Discuss Q1 2016 Earnings
-
Akers Biosciences to Present at 'Pioneers 2016' Investor Conference
-
Akers Board Rearrangement
-
Trading Radar for 4/26: Apple (AAPL), Chipotle (CMG), Twitter (TWTR), 3M ((MMM), Procter & Gamble (PG), Freeport-McMoRan (FCX) Report
-
Akers Biosciences Reports Earnings for Fiscal Year 2015
-
Akers Biosciences (AKER) Announces USPTO Allowance of Heparin/PF4 Antibody Detection-Related Patent
-
Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection
-
Akers Biosciences Announces Conference Call to Discuss Its 2015 Earnings
-
Akers Biosciences (AKER) Receives $2.5M PIFA Heparin/PF4 Product Supply Order
-
Akers Biosciences Announces $2.5M Order to Supply PIFA Heparin/PF4 Products to China
-
Akers Biosciences Hires Leading Commercial Executives to Support Sales Growth
-
Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
-
Akers Biosciences Updates on Joint Venture in China
-
Akers Biosciences to Present at 8th Annual LD Micro Investor Conference
-
Akers Biosciences Appoints Medical Technology Specialist as CEO
-
Akers Biosciences Announces Q3 2015 Earnings
-
Akers Biosciences Announces Q3 2015 Earnings
-
Akers Biosciences Appoints Dr. Raza Bokhari as Non-executive Director
-
Akers Biosciences Appoints Dr. Raza Bokhari as Non-executive Director
-
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter 2015 Earnings
-
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter 2015 Earnings
-
Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
-
Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
-
Akers Biosciences Commercializes New App-Enabled Tests for Health and Wellness Industry and Consumers
-
Akers Biosciences Commercializes New App-Enabled Tests for Health and Wellness Industry and Consumers
-
Akers Biosciences Signs Distribution Deals in India, Germany, Italy & Scandinavia
-
Akers Biosciences Signs Distribution Deals in India, Germany, Italy & Scandinavia
-
Akers Biosciences Launches METRON(R) - the First and Only Disposable Breath Ketone Test
-
Akers Biosciences Launches METRON(R) - the First and Only Disposable Breath Ketone Test
-
Akers Biosciences to Present at Rodman & Renshaw 17th Annual Global Investment Conference
-
Akers Biosciences to Present at Rodman & Renshaw 17th Annual Global Investment Conference
-
Akers Biosciences Announces Q2 2015 Earnings
-
Akers Biosciences Announces Rescheduling of Conference Call to Discuss Its Second Quarter & First Half 2015 Earnings
-
Akers Biosciences Announces Rescheduling of Conference Call to Discuss Its Second Quarter & First Half 2015 Earnings
-
Akers Biosciences Announces Conference Call to Discuss Its Second Quarter & First Half 2015 Earnings
-
Akers Biosciences Announces Conference Call to Discuss Its Second Quarter & First Half 2015 Earnings
-
Trading Radar for 7/28: Ford (F), Twitter (TWTR) DuPont (DD), Pfizer (PFE), UPS (UPS), US Steel (X) Report
-
Akers Biosciences Appoints Former Congressman Rob Andrews to the Board

